Christophe Hardouin

1.7k total citations
23 papers, 1.4k citations indexed

About

Christophe Hardouin is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Christophe Hardouin has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Christophe Hardouin's work include Chemical Synthesis and Analysis (12 papers), Cannabis and Cannabinoid Research (5 papers) and Fluorine in Organic Chemistry (4 papers). Christophe Hardouin is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Cannabis and Cannabinoid Research (5 papers) and Fluorine in Organic Chemistry (4 papers). Christophe Hardouin collaborates with scholars based in France, United States and China. Christophe Hardouin's co-authors include Dale L. Boger, Donmienne Leung, Benjamin F. Cravatt, Inkyu Hwang, Eric Doris, Aron H. Lichtman, Alan Saghatelian, Christopher C. Shelton, Wu Du and Heng Cheng and has published in prestigious journals such as Journal of the American Chemical Society, Nature Biotechnology and Journal of Medicinal Chemistry.

In The Last Decade

Christophe Hardouin

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Christophe Hardouin

Since Specialization

Citations

This map shows the geographic impact of Christophe Hardouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Hardouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Hardouin more than expected).

Fields of papers citing papers by Christophe Hardouin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Hardouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Hardouin. The network helps show where Christophe Hardouin may publish in the future.

Co-authorship network of co-authors of Christophe Hardouin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Hardouin. A scholar is included among the top collaborators of Christophe Hardouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Hardouin. Christophe Hardouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Large Scale Synthesis of an Ampakine-type Active Pharmaceutical Ingredient Based on a Telescoped Regioselective Double Amidation Reaction 2019 ·Organic Process Research & Development ·Christophe Hardouin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Peng Zhang, Weiwei Zhao, Xueyan Zhu	4
2	Multikilogram Synthesis of a Potent Dual Bcl-2/Bcl-x_L Antagonist. 2. Manufacture of the 1,3-Diamine Moiety and Improvement of the Final Coupling Reaction 2019 ·Organic Process Research & Development ·Christophe Hardouin, (unknown), (unknown), (unknown), (unknown), (unknown), Stéphane Le Roux, (unknown), Olivier Russo	2
3	Multikilogram Synthesis of a Potent Dual Bcl-2/Bcl-x_L Antagonist. 1. Manufacture of the Acid Moiety and Development of Some Key Reactions 2019 ·Organic Process Research & Development ·Christophe Hardouin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stéphane Le Roux, Olivier Russo, (unknown)	13
4	Copper‐Photocatalyzed Borylation of Organic Halides under Batch and Continuous‐Flow Conditions 2019 ·Chemistry - A European Journal ·Antoine Nitelet, Damien Thévenet, (unknown), Christophe Hardouin, Jean Fournier, (unknown), Xavier Pannecoucke, Philippe Jubault, Thomas Poisson	53
5	Development of an Efficient Synthesis of an Agonist of Acetylcholine Nicotinic Receptor 2018 ·Organic Process Research & Development ·Christophe Hardouin, (unknown), (unknown), (unknown), Thierry Dubuffet, (unknown), Patrick Mouchet	0
6	Scalable asymmetric synthesis of a key fragment of Bcl-2/Bcl-_xL inhibitors 2014 ·RSC Advances ·Sylvain Laclef, Catherine Taillier, (unknown), (unknown), Jean‐François Brière, Christophe Hardouin, Vincent Levacher	7
7	Synthesis of new chiral 2-functionalized-1,2,3,4-tetrahydroquinoline derivatives via asymmetric hydrogenation of substituted quinolines 2013 ·Tetrahedron ·(unknown), Isabelle Suisse, Christophe Hardouin, Francine Agbossou‐Niedercorn	26
8	Highly enantioselective hydrogenation of new 2-functionalized quinoline derivatives 2012 ·Tetrahedron Letters ·(unknown), Isabelle Suisse, (unknown), Christophe Hardouin, Francine Agbossou‐Niedercorn	26
9	Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity 2005 ·Bioorganic & Medicinal Chemistry Letters ·Donmienne Leung, Wu Du, Christophe Hardouin, Heng Cheng, Inkyu Hwang, Benjamin F. Cravatt, Dale L. Boger	93
10	Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Aron H. Lichtman, Donmienne Leung, Christopher C. Shelton, Alan Saghatelian, Christophe Hardouin, Dale L. Boger, Benjamin F. Cravatt	282
11	Heterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Wu Du, Christophe Hardouin, Heng Cheng, Inkyu Hwang, Dale L. Boger	28
12	Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics 2004 ·Journal of Medicinal Chemistry ·Dale L. Boger, Hiroshi Miyauchi, Wu Du, Christophe Hardouin, Robert Fecik, Heng Cheng, Inkyu Hwang, Michael P. Hedrick, Donmienne Leung, Orlando Acevedo, Cristiano R. W. Guimarães, William L. Jorgensen, Benjamin F. Cravatt	187
13	Discovering potent and selective reversible inhibitors of enzymes in complex proteomes 2003 ·Nature Biotechnology ·Donmienne Leung, Christophe Hardouin, Dale L. Boger, Benjamin F. Cravatt	329
14	Fundamental Role of the Fostriecin Unsaturated Lactone and Implications for Selective Protein Phosphatase Inhibition 2003 ·Journal of the American Chemical Society ·Suzanne B. Buck, Christophe Hardouin, Satoshi Ichikawa, D. R. Soenen, Carla‐Maria Gauss, Inkyu Hwang, Mark R. Swingle, (unknown), Richard E. Honkanen, Dale L. Boger	104
15	Enantioselective synthesis of chromenes 2003 ·Tetrahedron Letters ·Christophe Hardouin, (unknown), Alain Valleix, Eric Doris	32
16	Cp2TiCl-mediated selective reduction of α,β-unsaturated ketones 2002 ·Tetrahedron Letters ·Lionel Moisan, Christophe Hardouin, Bernard Rousseau, Eric Doris	28
17	Selective Deoxygenation of Leurosine: Concise Access to Anhydrovinblastine 2002 ·The Journal of Organic Chemistry ·Christophe Hardouin, Eric Doris, Bernard Rousseau, Charles Mioskowski	19
18	BF₃·OEt₂-Mediated Rearrangement of Cyclopropyl Carbinols: A Concise Route to Polycyclic Cyclobutanes 2001 ·The Journal of Organic Chemistry ·Christophe Hardouin, Frédéric Taran, Eric Doris	20
19	Cp₂TiCl-Mediated Selective Reduction of α,β-Epoxy Ketones 2001 ·The Journal of Organic Chemistry ·Christophe Hardouin, Floris Chevallier, Bernard Rousseau, Eric Doris	49
20	Leurosine methiodide–methanol–water (1/3/2) 2000 ·Acta Crystallographica Section C Crystal Structure Communications ·Christophe Hardouin, Eric Doris, Bernard Rousseau, Charles Mioskowski, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact